Trademarkia Logo

Canada

C$
Trademark Search in Canada
LIGHT AND QUADRILATERAL DESIGN

View On IC.GC.CA

LIGHT AND QUADRILATERAL DESIGN
SEARCHED

on 9 May 2025

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2237009 filed on 6th Dec 2022

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

LIGHT AND QUADRILATERAL DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely central nervous system infections, brain diseases, Read More

Vienna Information

1 . 15 . 9

Luminous sources, rays, shafts of lightSources lumineuses, rayons, faisceaux de lumière

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

29 . 1 . 3

GreenVert

29 . 1 . 4

BlueBleu

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunological diseases, namely autoimmune diseases, immune deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Pharmaceutical preparations for the prevention and treatment of musculoskeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; Pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, pelvic inflammatory diseases; Pharmaceutical preparations used in dermatology, namely dermatitis, diseases affecting skin pigmentation, sexually transmitted diseases; Pharmaceutical preparations used in oncology; Pharmaceutical preparations used in haematology, namely for the treatment of blood disorders; Pharmaceutical preparations used for tissue and organ transplantation; Pharmaceutical preparations used in ophthalmology; Pharmaceutical preparations used in gastroenterology; Pharmaceutical preparations for the prevention and treatment of eye disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.

Classification kind code

11

Mark Details

Serial Number

2237009

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 12th Nov 2024		Agent Changed
Submitted for opposition 22
on 23rd May 2024		Search Recorded
Submitted for opposition 20
on 23rd May 2024		Examiner's First Report
Submitted for opposition 223
on 23rd May 2024		Total Provisional Refusal
Submitted for opposition 256
on 4th Dec 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 2th Feb 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 1st Feb 2023		Created
Submitted for opposition 31
on 1st Feb 2023		Formalized
Submitted for opposition 30
on 6th Dec 2022		Filed
Submitted for opposition 228
on 5th Jul 2022		International Registration